GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Cyclically Adjusted PB Ratio

Cereno Scientific AB (OSTO:CRNO B) Cyclically Adjusted PB Ratio : 4.59 (As of Jul. 15, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Cyclically Adjusted PB Ratio?

As of today (2025-07-15), Cereno Scientific AB's current share price is kr8.82. Cereno Scientific AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr1.92. Cereno Scientific AB's Cyclically Adjusted PB Ratio for today is 4.59.

The historical rank and industry rank for Cereno Scientific AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:CRNO B' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 4.83
Current: 4.83

During the past years, Cereno Scientific AB's highest Cyclically Adjusted PB Ratio was 4.83. The lowest was 0.00. And the median was 0.00.

OSTO:CRNO B's Cyclically Adjusted PB Ratio is ranked worse than
78.95% of 746 companies
in the Drug Manufacturers industry
Industry Median: 2.04 vs OSTO:CRNO B: 4.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cereno Scientific AB's adjusted book value per share data for the three months ended in Mar. 2025 was kr0.593. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.92 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cereno Scientific AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cereno Scientific AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Cyclically Adjusted PB Ratio Chart

Cereno Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cereno Scientific AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 2.93

Competitive Comparison of Cereno Scientific AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cereno Scientific AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's Cyclically Adjusted PB Ratio falls into.


;
;

Cereno Scientific AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cereno Scientific AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.82/1.92
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cereno Scientific AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cereno Scientific AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.593/132.8245*132.8245
=0.593

Current CPI (Mar. 2025) = 132.8245.

Cereno Scientific AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.995 0.000
201509 0.000 100.228 0.000
201512 0.068 100.276 0.090
201603 0.000 100.751 0.000
201606 2.751 101.019 3.617
201609 2.655 101.138 3.487
201612 2.563 102.022 3.337
201703 2.496 102.022 3.250
201706 2.394 102.752 3.095
201709 2.283 103.279 2.936
201712 2.141 103.793 2.740
201803 1.977 103.962 2.526
201806 1.531 104.875 1.939
201809 1.679 105.679 2.110
201812 1.597 105.912 2.003
201903 1.019 105.886 1.278
201906 2.326 106.742 2.894
201909 1.567 107.214 1.941
201912 1.483 107.766 1.828
202003 1.390 106.563 1.733
202006 1.290 107.498 1.594
202009 2.609 107.635 3.220
202012 1.389 108.296 1.704
202103 1.334 108.360 1.635
202106 1.266 108.928 1.544
202109 2.493 110.338 3.001
202112 1.616 112.486 1.908
202203 1.566 114.825 1.811
202206 1.502 118.384 1.685
202209 1.995 122.296 2.167
202212 1.465 126.365 1.540
202303 1.433 127.042 1.498
202306 1.059 129.407 1.087
202309 1.011 130.224 1.031
202312 0.926 131.912 0.932
202403 0.860 132.205 0.864
202406 0.900 132.716 0.901
202409 0.819 132.304 0.822
202412 0.681 132.987 0.680
202503 0.593 132.825 0.593

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cereno Scientific AB  (OSTO:CRNO B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cereno Scientific AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cereno Scientific AB Business Description

Traded in Other Exchanges
Address
BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines